Skip to content

Clinical trials

Kidney Failure, Chronic trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Kidney Failure, Chronic Country / region: Italy Clear all

73 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20043
20051
20061
20074
20084
20097
20102
20113
20127
20133
20144
20152
20161
20172
20181
20191
20203
20213
20227
20233
20246
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed37
Recruiting10
Unknown status10
Terminated6
Active, not recruiting5
Withdrawn3
Not yet recruiting1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Iperboreal Pharma Srl6
Heidelberg University4
IRCCS Azienda Ospedaliero-Universitaria di Bologna3
Mario Negri Institute for Pharmacological Research3
A.O.U. Città della Salute e della Scienza2
Affymax2
Italian Society of Nephrology2
Vantive Health LLC2
W.L.Gore & Associates2
Xeltis2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Kidney Failure, Chronic73
Renal Insufficiency, Chronic20
Anemia7
Cardiovascular Diseases6
Diabetes Mellitus6
Kidney Diseases5
Renal Insufficiency4
Vascular Diseases4
Atherosclerosis3
Disease Progression3

Trials

Showing 76 to 73 of 73. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.